Local melatoninergic system as the protector of skin integrity

International Journal of Molecular Sciences

Volumn 15, Issue 10, 2014, Pages 17705-17732

  Slominski, Andrzej T ^a   Kleszczyński, Konrad ^b   Semak, Igor ^c   Janjetovic, Zorica ^a   Żmijewski, Michał A ^d   Kim, Tae Kang ^a   Slominski, Radomir M ^a   Reiter, Russel J ^e   Fischer, Tobias W ^b  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b UNIVERSITY OF LÜBECK   (Germany)

^c BELARUSIAN STATE UNIVERSITY   (Belarus)

^d MEDICAL UNIVERSITY OF GDANSK   (Poland)

^e UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

6 hydroxymelatonin; AFMK; Human full thickness skin; Keratinocytes; Melatonin; Oxidative stress; Ultraviolet radiation

Indexed keywords

LACTATE DEHYDROGENASE; MELATONIN; MELATONIN RECEPTOR; SEROTONIN; TRYPTOPHAN; TRYPTOPHAN HYDROXYLASE 2;

CARCINOGENESIS; CIRCADIAN RHYTHM; CUTANEOUS PARAMETERS; DNA DAMAGE; GENE EXPRESSION; HUMAN; LIGHT DAMAGE; METABOLITE; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; NONHUMAN; OXIDATIVE STRESS; REVIEW; SIGNAL TRANSDUCTION; SKIN PROTECTION; SURVIVAL FACTOR; ULTRAVIOLET RADIATION; CYTOLOGY; DRUG EFFECTS; KERATINOCYTE; METABOLISM; RADIATION RESPONSE; SKIN;

HUMANS; KERATINOCYTES; MELATONIN; MEMBRANE POTENTIAL, MITOCHONDRIAL; OXIDATIVE STRESS; RECEPTORS, MELATONIN; SKIN; ULTRAVIOLET RAYS;

EID: 84907841510     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms151017705     Document Type: Review

References (155)

1. Lerner, A. B.; Case, J. D.; Takahashi, Y. Isolation of melatonin and 5-methoxyindole-3-acetic acid from bovine pineal glands. J. Biol. Chem. 1960, 235, 1992-1997.
2. Reiter, R. J. Pineal melatonin: Cell biology of its synthesis and of its physiological interactions. Endocr. Rev. 1991, 12, 151-180.
3. Friedman, P. A.; Kappelman, A. H.; Kaufman, S. Partial purification and characterization of tryptophan hydroxylase from rabbit hindbrain. J. Biol. Chem. 1972, 247, 4165-4173.
4. Windahl, M. S.; Petersen, C. R.; Christensen, H. E.; Harris, P. Crystal structure of tryptophan hydroxylase with bound amino acid substrate. Biochemistry 2008, 47, 12087-12094.
5. Mockus, S. M.; Vrana, K. E. Advances in the molecular characterization of tryptophan hydroxylase. J. Mol. Neurosci. 1998, 10, 163-179.
6. Walther, D. J.; Bader, M. A unique central tryptophan hydroxylase isoform. Biochem. Pharmacol. 2003, 66, 1673-1680.
7. Sakowski, S. A.; Geddes, T. J.; Thomas, D. M.; Levi, E.; Hatfield, J. S.; Kuhn, D. M. Differential tissue distribution of tryptophan hydroxylase isoforms 1 and 2 as revealed with monospecific antibodies. Brain Res. 2006, 1085, 11-18.
8. Amireault, P.; Sibon, D.; Cote, F. Life without peripheral serotonin: Insights from tryptophan hydroxylase 1 knockout mice reveal the existence of paracrine/autocrine serotonergic networks. ACS Chem. Neurosci. 2013, 4, 64-71.
9. Slominski, A.; Pisarchik, A.; Semak, I.; Sweatman, T.; Szczesniewski, A.; Wortsman, J. Serotoninergic system in hamster skin. J. Investig. Dermatol. 2002, 119, 934-942.
10. Slominski, A.; Pisarchik, A.; Semak, I.; Sweatman, T.; Wortsman, J. Characterization of the serotoninergic system in the C57BL/6 mouse skin. Eur. J. Biochem. 2003, 270, 3335-3344.
11. Walther, D. J.; Peter, J. U.; Bashammakh, S.; Hortnagl, H.; Voits, M.; Fink, H.; Bader, M. Synthesis of serotonin by a second tryptophan hydroxylase isoform. Science 2003, 299, 76.
12. Lovenberg, W.; Weissbach, H.; Udenfriend, S. Aromatic L-amino acid decarboxylase. J. Biol. Chem. 1962, 237, 89-93.
13. Lovenberg, W.; Jequier, E.; Sjoerdsma, A. Tryptophan hydroxylation: Measurement in pineal gland, brainstem, and carcinoid tumor. Science 1967, 155, 217-219.
14. Coon, S. L.; Mazuruk, K.; Bernard, M.; Roseboom, P. H.; Klein, D. C.; Rodriguez, I. R. The human serotonin N-acetyltransferase (EC 2. 3. 1. 87) gene (AANAT): Structure, chromosomal localization, and tissue expression. Genomics 1996, 34, 76-84.
15. Falcon, J.; Coon, S. L.; Besseau, L.; Cazamea-Catalan, D.; Fuentes, M.; Magnanou, E.; Paulin, C. H.; Boeuf, G.; Sauzet, S.; Jorgensen, E. H.; et al. Drastic neofunctionalization associated with evolution of the timezyme AANAT 500 Mya. Proc. Natl. Acad. Sci. USA 2014, 111, 314-319.
16. Weissbach, A. A novel system for the incorporation of amino acids by extracts of E. coli B. Biochim. Biophys. Acta 1960, 41, 498-509.
17. Reiter, R. J.; Tan, D. X.; Terron, M. P.; Flores, L. J.; Czarnocki, Z. Melatonin and its metabolites: New findings regarding their production and their radical scavenging actions. Acta Biochim. Pol. 2007, 54, 1-9.
18. Liu, T.; Borjigin, J. N-acetyltransferase is not the rate-limiting enzyme of melatonin synthesis at night. J. Pineal Res. 2005, 39, 91-96.
19. Semak, I.; Korik, E.; Naumova, M.; Wortsman, J.; Slominski, A. Serotonin metabolism in rat skin: Characterization by liquid chromatography-mass spectrometry. Arch. Biochem. Biophys. 2004, 421, 61-66.
20. Gaudet, S. J.; Slominski, A.; Etminan, M.; Pruski, D.; Paus, R.; Namboodiri, M. A. Identification and characterization of two isozymic forms of arylamine N-acetyltransferase in Syrian hamster skin. J. Investig. Dermatol. 1993, 101, 660-665.
21. Roseboom, P. H.; Namboodiri, M. A.; Zimonjic, D. B.; Popescu, N. C.; Rodriguez, I. R.; Gastel, J. A.; Klein, D. C. Natural melatonin "knockdown" in C57BL/6J mice: Rare mechanism truncates serotonin N-acetyltransferase. Brain Res. Mol. Brain Res. 1998, 63, 189-197.
22. Slominski, A.; Semak, I.; Pisarchik, A.; Sweatman, T.; Szczesniewski, A.; Wortsman, J. Conversion of L-tryptophan to serotonin and melatonin in human melanoma cells. FEBS Lett. 2002, 511, 102-106.
23. Slominski, A.; Wortsman, J.; Tobin, D. J. The cutaneous serotoninergic/melatoninergic system: Securing a place under the sun. FASEB J. 2005, 19, 176-194.
24. Kobayashi, H.; Kromminga, A.; Dunlop, T. W.; Tychsen, B.; Conrad, F.; Suzuki, N.; Memezawa, A.; Bettermann, A.; Aiba, S.; Carlberg, C.; et al. A role of melatonin in neuroectodermal-mesodermal interactions: The hair follicle synthesizes melatonin and expresses functional melatonin receptors. FASEB J. 2005, 19, 1710-1712.
25. Slominski, A.; Tobin, D. J.; Zmijewski, M. A.; Wortsman, J.; Paus, R. Melatonin in the skin: Synthesis, metabolism and functions. Trends Endocrinol. MeTable 2008, 19, 17-24.
26. Slominski, A.; Pisarchik, A.; Johansson, O.; Jing, C.; Semak, I.; Slugocki, G.; Wortsman, J. Tryptophan hydroxylase expression in human skin cells. Biochim. Biophys. Acta 2003, 1639, 80-86.
27. Slominski, A.; Pisarchik, A.; Semak, I.; Sweatman, T.; Wortsman, J.; Szczesniewski, A.; Slugocki, G.; McNulty, J.; Kauser, S.; Tobin, D. J.; et al. Serotoninergic and melatoninergic systems are fully expressed in human skin. FASEB J. 2002, 16, 896-898.
28. Kim, T. K.; Lin, Z.; Tidwell, W. J.; Li, W.; Slominski, A. T. Melatonin and its metabolites accumulate in the human epidermis in vivo and inhibit proliferation and tyrosinase activity in epidermal melanocytes in vitro. Mol. Cell. Endocrinol 2014, in press, doi: 10. 1016/j. mce. 2014. 07. 024.
29. Slominski, A.; Baker, J.; Rosano, T. G.; Guisti, L. W.; Ermak, G.; Grande, M.; Gaudet, S. J. Metabolism of serotonin to N-acetylserotonin, melatonin, and 5-methoxytryptamine in hamster skin culture. J. Biol. Chem. 1996, 271, 12281-12286.
30. Zmijewski, M. A.; Sweatman, T. W.; Slominski, A. T. The melatonin-producing system is fully functional in retinal pigment epithelium (ARPE-19). Mol. Cell. Endocrinol. 2009, 307, 211-216.
31. Kim, T. K.; Kleszczynski, K.; Janjetovic, Z.; Sweatman, T.; Lin, Z.; Li, W.; Reiter, R. J.; Fischer, T. W.; Slominski, A. T. Metabolism of melatonin and biological activity of intermediates of melatoninergic pathway in human skin cells. FASEB J. 2013, 27, 2742-2755.
32. Hardeland, R. Chronobiology of melatonin beyond the feedback to the suprachiasmatic nucleus-consequences to melatonin dysfunction. Int. J. Mol. Sci. 2013, 14, 5817-5841.
33. Reiter, R. J. The melatonin rhythm: Both a clock and a calendar. Experientia 1993, 49, 654-664.
34. Mauriz, J. L.; Collado, P. S.; Veneroso, C.; Reiter, R. J.; Gonzalez-Gallego, J. A review of the molecular aspects of melatonin's anti-inflammatory actions: Recent insights and new perspectives. J. Pineal Res. 2013, 54, 1-14.
35. Calvo, J. R.; Gonzalez-Yanes, C.; Maldonado, M. D. The role of melatonin in the cells of the innate immunity: A review. J. Pineal Res. 2013, 55, 103-120.
36. Reiter, R. J.; Tan, D. X.; Manchester, L. C.; Paredes, S. D.; Mayo, J. C.; Sainz, R. M. Melatonin and reproduction revisited. Biol. Reprod. 2009, 81, 445-456.
37. Cipolla-Neto, J.; Amaral, F. G.; Afeche, S. C.; Tan, D. X.; Reiter, R. J. Melatonin, energy metabolism, and obesity: A review. J. Pineal Res. 2014, 56, 371-381.
38. Acuna-Castroviejo, D.; Escames, G.; Venegas, C.; Diaz-Casado, M. E.; Lima-Cabello, E.; Lopez, L. C.; Rosales-Corral, S.; Tan, D. X.; Reiter, R. J. Extrapineal melatonin: Sources, regulation, and potential functions. Cell. Mol. Life Sci. 2014, 71, 2997-3025.
39. Slominski, R. M.; Reiter, R. J.; Schlabritz-Loutsevitch, N.; Ostrom, R. S.; Slominski, A. T. Melatonin membrane receptors in peripheral tissues: Distribution and functions. Mol. Cell. Endocrinol. 2012, 351, 152-66.
40. Dauchy, R. T.; Xiang, S.; Mao, L.; Brimer, S.; Wren, M. A.; Yuan, L.; Anbalagan, M.; Hauch, A.; Frasch, T.; Rowan, B. G.; et al. Circadian and melatonin disruption by exposure to light at night drives intrinsic resistance to tamoxifen therapy in breast cancer. Cancer Res. 2014, 74, 4099-4110.
41. Sanchez-Hidalgo, M.; Lee, M.; de la Lastra, C. A.; Guerrero, J. M.; Packham, G. Melatonin inhibits cell proliferation and induces caspase activation and apoptosis in human malignant lymphoid cell lines. J. Pineal Res. 2012, 53, 366-373.
42. Bizzarri, M.; Proietti, S.; Cucina, A.; Reiter, R. J. Molecular mechanisms of the pro-apoptotic actions of melatonin in cancer: A review. Expert Opin. Ther. Targets 2013, 17, 1483-1496.
43. Reiter, R. J.; Tan, D. X.; Kim, S. J.; Cruz, M. H. C. Delivery of pineal melatonin to the brain and SCN: Role of canaliculi, cerebrospinal fluid, tymocytes and Virchow-Robin perivacular spaces. Brain Struct. Funct. 2014, in press.
44. Menendez-Pelaez, A.; Reiter, R. J. Distribution of melatonin in mammalian tissues: The relative importance of nuclear versus cytosolic localization. J. Pineal Res. 1993, 15, 59-69.
45. Reiter, R. J.; Tan, D. X.; Rosales-Corral, S.; Manchester, L. C. The universal nature, unequal distribution and antioxidant functions of melatonin and its derivatives. Mini Rev. Med. Chem. 2013, 13, 373-384.
46. Venegas, C.; Garcia, J. A.; Escames, G.; Ortiz, F.; Lopez, A.; Doerrier, C.; Garcia-Corzo, L.; Lopez, L. C.; Reiter, R. J.; Acuna-Castroviejo, D. Extrapineal melatonin: Analysis of its subcellular distribution and daily fluctuations. J. Pineal Res. 2012, 52, 217-227.
47. Liu, R.; Fu, A.; Hoffman, A. E.; Zheng, T.; Zhu, Y. Melatonin enhances DNA repair capacity possibly by affecting genes involved in DNA damage responsive pathways. BMC Cell. Biol. 2013, 14, 1.
48. 2)-formyl-5-methoxykynuramine, resveratrol and uric acid. Int. J. Biochem. Cell. Biol. 2001, 33, 775-783.
49. Dubocovich, M. L.; Markowska, M. Functional MT1 and MT2 melatonin receptors in mammals. Endocrine 2005, 27, 101-110.
50. Reiter, R. J.; Tan, D. X.; Manchester, L. C.; Pilar Terron, M.; Flores, L. J.; Koppisepi, S. Medical implications of melatonin: Receptor-mediated and receptor-independent actions. Adv. Med. Sci. 2007, 52, 11-28.
51. Galano, A.; Tan, D. X.; Reiter, R. J. On the free radical scavenging activities of melatonin's metabolites, AFMK and AMK. J. Pineal Res. 2013, 54, 245-257.
52. Kleszczynski, K.; Fischer, T. W. Melatonin and human skin aging. Dermatoendocrinol 2012, 4, 245-252.
53. Slominski, A.; Pisarchik, A.; Zbytek, B.; Tobin, D. J.; Kauser, S.; Wortsman, J. Functional activity of serotoninergic and melatoninergic systems expressed in the skin. J. Cell. Physiol. 2003, 196, 144-153.
54. Fischer, T. W.; Slominski, A.; Tobin, D. J.; Paus, R. Melatonin and the hair follicle. J. Pineal Res. 2008, 44, 1-15.
55. Slominski, A.; Pruski, D. Melatonin inhibits proliferation and melanogenesis in rodent melanoma cells. Exp. Cell. Res. 1993, 206, 189-194.
56. Slominski, A.; Chassalevris, N.; Mazurkiewicz, J.; Maurer, M.; Paus, R. Murine skin as a target for melatonin bioregulation. Exp. Dermatol. 1994, 3, 45-50.
57. Slominski, A.; Fischer, T. W.; Zmijewski, M. A.; Wortsman, J.; Semak, I.; Zbytek, B.; Slominski, R. M.; Tobin, D. J. On the role of melatonin in skin physiology and pathology. Endocrine 2005, 27, 137-148.
58. Slominski, A.; Pisarchik, A.; Wortsman, J. Expression of genes coding melatonin and serotonin receptors in rodent skin. Biochim. Biophys. Acta 2004, 1680, 67-70.
59. Fischer, T. W.; Zmijewski, M. A.; Zbytek, B.; Sweatman, T. W.; Slominski, R. M.; Wortsman, J.; Slominski, A. Oncostatic effects of the indole melatonin and expression of its cytosolic and nuclear receptors in cultured human melanoma cell lines. Int. J. Oncol. 2006, 29, 665-672.
60. Slominski, A. T.; Kim, T. K.; Takeda, Y.; Janjetovic, Z.; Brozyna, A. A.; Skobowiat, C.; Wang, J.; Postlethwaite, A.; Li, W.; Tuckey, R. C.; et al. RORalpha and ROR gamma are expressed in human skin and serve as receptors for endogenously produced noncalcemic 20-hydroxy-and 20, 23-dihydroxyvitamin D. FASEB J. 2014, 28, 2775-2789.
61. Hardeland, R.; Reiter, R. J.; Poeggeler, B.; Tan, D. X. The significance of the metabolism of the neurohormone melatonin: Antioxidative protection and formation of bioactive substances. Neurosci. Biobehav. Rev. 1993, 17, 347-357.
62. Grace, M. S.; Cahill, G. M.; Besharse, J. C. Melatonin deacetylation: Retinal vertebrate class distribution and Xenopus laevis tissue distribution. Brain Res. 1991, 559, 56-63.
63. Ma, X.; Idle, J. R.; Krausz, K. W.; Gonzalez, F. J. Metabolism of melatonin by human cytochromes p450. Drug Metab Dispos. 2005, 33, 489-494.
64. Arendt, J. Melatonin. Clin. Endocrinol. (Oxf.) 1988, 29, 205-229.
65. Rogawski, M. A.; Roth, R. H.; Aghajanian, G. K. Melatonin: Deacetylation to 5-methoxytryptamine by liver but not brain aryl acylamidase. J. Neurochem. 1979, 32, 1219-26.
66. Hirata, F.; Hayaishi, O.; Tokuyama, T.; Seno, S. In vitro and in vivo formation of two new metabolites of melatonin. J. Biol. Chem. 1974, 249, 1311-1313.
67. 1)-acetyl-5-methoxykynuramine with carbamoyl phosphate and related compounds. J. Pineal Res. 2010, 48, 47-54.
68. Hardeland, R.; Backhaus, C.; Fadavi, A. Reactions of the NO redox forms NO+, *NO and HNO (protonated NO-) with the melatonin metabolite N1-acetyl-5-methoxykynuramine. J. Pineal Res. 2007, 43, 382-388.
69. Fischer, T. W.; Sweatman, T. W.; Semak, I.; Sayre, R. M.; Wortsman, J.; Slominski, A. Constitutive and UV-induced metabolism of melatonin in keratinocytes and cell-free systems. FASEB J. 2006, 20, 1564-1566.
70. Slominski, A. T.; Zmijewski, M. A.; Skobowiat, C.; Zbytek, B.; Slominski, R. M.; Steketee, J. D. Sensing the environment: Regulation of local and global homeostasis by the skin's neuroendocrine system. Adv. Anat. Embryol. Cell. Biol. 2012, 212, 1-115.
71. Slominski, A.; Wortsman, J. Neuroendocrinology of the skin. Endocr. Rev. 2000, 21, 457-487.
72. Slominski, A.; Wortsman, J.; Luger, T.; Paus, R.; Solomon, S. Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. Physiol. Rev. 2000, 80, 979-1020.
73. Slominski, A. T.; Zmijewski, M. A.; Zbytek, B.; Tobin, D. J.; Theoharides, T. C.; Rivier, J. Key role of CRF in the skin stress response system. Endocr. Rev. 2013, 34, 827-884.
74. Slominski, A.; Wortsman, J.; Pisarchik, A.; Zbytek, B.; Linton, E. A.; Mazurkiewicz, J. E.; Wei, E. T. Cutaneous expression of corticotropin-releasing hormone (CRH), urocortin, and CRH receptors. FASEB J. 2001, 15, 1678-1693.
75. Slominski, A.; Wortsman, J.; Kohn, L.; Ain, K. B.; Venkataraman, G. M.; Pisarchik, A.; Chung, J. H.; Giuliani, C.; Thornton, M.; Slugocki, G.; et al. Expression of hypothalamic-pituitary-thyroid axis related genes in the human skin. J. Investig. Dermatol. 2002, 119, 1449-1455.
76. Bohm, M.; Luger, T. A.; Tobin, D. J.; Garcia-Borron, J. C. Melanocortin receptor ligands: New horizons for skin biology and clinical dermatology. J. Investig. Dermatol. 2006, 126, 1966-1975.
77. Slominski, A.; Zbytek, B.; Nikolakis, G.; Manna, P. R.; Skobowiat, C.; Zmijewski, M.; Li, W.; Janjetovic, Z.; Postlethwaite, A.; Zouboulis, C. C.; et al. Steroidogenesis in the skin: Implications for local immune functions. J. Steroid Biochem. Mol. Biol. 2013, 137, 107-123.
78. Dixon, K. M.; Tongkao-On, W.; Sequeira, V. B.; Carter, S. E.; Song, E. J.; Rybchyn, M. S.; Gordon-Thomson, C.; Mason, R. S. Vitamin d and death by sunshine. Int. J. Mol. Sci. 2013, 14, 1964-1977.
79. Song, E. J.; Gordon-Thomson, C.; Cole, L.; Stern, H.; Halliday, G. M.; Damian, D. L.; Reeve, V. E.; Mason, R. S. 1alpha, 25-Dihydroxyvitamin D3 reduces several types of UV-induced DNA damage and contributes to photoprotection. J. Steroid Biochem. Mol. Biol. 2013, 136, 131-138.
80. Slominski, A. T.; Kim, T. K.; Li, W.; Yi, A. K.; Postlethwaite, A.; Tuckey, R. C. The role of CYP11A1 in the production of vitamin D metabolites and their role in the regulation of epidermal functions. J. Steroid Biochem. Mol. Biol. 2014, 144PA, 28-39.
81. Bikle, D. D.; Elalieh, H.; Welsh, J.; Oh, D.; Cleaver, J.; Teichert, A. Protective role of vitamin D signaling in skin cancer formation. J. Steroid Biochem. Mol. Biol. 2013, 136, 271-279.
82. Slominski, A. T.; Kim, T. K.; Shehabi, H. Z.; Tang, E. K.; Benson, H. A.; Semak, I.; Lin, Z.; Yates, C. R.; Wang, J.; Li, W.; et al. In vivo production of novel vitamin D2 hydroxy-derivatives by human placentas, epidermal keratinocytes, Caco-2 colon cells and the adrenal gland. Mol. Cell. Endocrinol. 2014, 383, 181-192.
83. Slominski, A.; Kim, T. K.; Zmijewski, M. A.; Janjetovic, Z.; Li, W.; Chen, J.; Kusniatsova, E. I.; Semak, I.; Postlethwaite, A.; Miller, D. D.; et al. Novel vitamin D photoproducts and their precursors in the skin. Dermatoendocrinol 2013, 5, 7-19.
84. Slominski, A. T.; Kim, T. K.; Shehabi, H. Z.; Semak, I.; Tang, E. K.; Nguyen, M. N.; Benson, H. A.; Korik, E.; Janjetovic, Z.; Chen, J.; et al. In vivo evidence for a novel pathway of vitamin D(3) metabolism initiated by P450scc and modified by CYP27B1. FASEB J. 2012, 26, 3901-3915.
85. Slominski, A. T.; Manna, P. R.; Tuckey, R. C. Cutaneous glucocorticosteroidogenesis: Securing local homeostasis and the skin integrity. Exp. Dermatol. 2014, 23, 369-374.
86. Slominski, A. T.; Kim, T. K.; Chen, J.; Nguyen, M. N.; Li, W.; Yates, C. R.; Sweatman, T.; Janjetovic, Z.; Tuckey, R. C. Cytochrome P450scc-dependent metabolism of 7-dehydrocholesterol in placenta and epidermal keratinocytes. Int. J. Biochem. Cell. Biol. 2012, 44, 2003-2018.
87. Slominski, A. T.; Zmijewski, M. A.; Semak, I.; Zbytek, B.; Pisarchik, A.; Li, W.; Zjawiony, J.; Tuckey, R. C. Cytochromes p450 and skin cancer: Role of local endocrine pathways. Anticancer Agents Med. Chem. 2014, 14, 77-96.
88. Slominski, A.; Kim, T. K.; Brozyna, A. A.; Janjetovic, Z.; Brooks, D. L.; Schwab, L. P.; Skobowiat, C.; Jozwicki, W.; Seagroves, T. N. The role of melanogenesis in regulation of melanoma behavior: Melanogenesis leads to stimulation of HIF-1alpha expression and HIF-dependent attendant pathways. Arch. Biochem. Biophys. 2014, in press, doi: 10. 1016/j. abb. 2014. 06. 030.
89. Slominski, A.; Tobin, D. J.; Shibahara, S.; Wortsman, J. Melanin pigmentation in mammalian skin and its hormonal regulation. Physiol. Rev. 2004, 84, 1155-228.
90. Slominski, A.; Zmijewski, M. A.; Pawelek, J. L-tyrosine and L-dihydroxyphenylalanine as hormone-like regulators of melanocyte functions. Pigment. Cell. Melanoma Res. 2012, 25, 14-27.
91. Fischer, T. W.; Slominski, A.; Zmijewski, M. A.; Reiter, R. J.; Paus, R. Melatonin as a major skin protectant: From free radical scavenging to DNA damage repair. Exp. Dermatol. 2008, 17, 713-730.
92. Scheuer, C.; Pommergaard, H. C.; Rosenberg, J.; Gogenur, I. Melatonin's protective effect against UV radiation: A systematic review of clinical and experimental studies. Photodermatol. Photoimmunol. Photomed. 2014, 30, 180-188.
93. Bohm, M.; Wolff, I.; Scholzen, T. E.; Robinson, S. J.; Healy, E.; Luger, T. A.; Schwarz, T.; Schwarz, A. alpha-Melanocyte-stimulating hormone protects from ultraviolet radiation-induced apoptosis and DNA damage. J. Biol. Chem. 2005, 280, 5795-5802.
94. Hardeland, R.; Coto-Montes, A.; Poeggeler, B. Circadian rhythms, oxidative stress, and antioxidative defense mechanisms. Chronobiol. Int. 2003, 20, 921-962.
95. Wilking, M.; Ndiaye, M.; Mukhtar, H.; Ahmad, N. Circadian rhythm connections to oxidative stress: Implications for human health. Antioxid Redox Signal. 2013, 19, 192-208.
96. Bailey, S. M.; Udoh, U. S.; Young, M. E. Circadian regulation of metabolism. J. Endocrinol. 2014, 222, R75-R96.
97. Desotelle, J. A.; Wilking, M. J.; Ahmad, N. The circadian control of skin and cutaneous photodamage. Photochem. Photobiol. 2012, 88, 1037-1047.
98. Gaddameedhi, S.; Selby, C. P.; Kaufmann, W. K.; Smart, R. C.; Sancar, A. Control of skin cancer by the circadian rhythm. Proc. Natl. Acad. Sci. USA 2011, 108, 18790-18795.
99. Feichtinger, R. G.; Sperl, W.; Bauer, J. W.; Kofler, B. Mitochondrial dysfunction: A neglected component of skin diseases. Exp. Dermatol. 2014, in press.
100. Birch-Machin, M. A. Mitochondria and skin disease. Clin. Exp. Dermatol. 2000, 25, 141-146.
101. Mayo, J. C.; Tan, D. X.; Sainz, R. M.; Lopez-Burillo, S.; Reiter, R. J. Oxidative damage to catalase induced by peroxyl radicals: Functional protection by melatonin and other antioxidants. Free Radic Res. 2003, 37, 543-553.
102. Di Mascio, P.; Dewez, B.; Garcia, C. R. Ghost protein damage by peroxynitrite and its protection by melatonin. Braz J. Med. Biol. Res. 2000, 33, 11-17.
103. Martinez-Cruz, F.; Guerrero, J. M.; Osuna, C. Melatonin prevents the formation of pyrrolized proteins in human plasma induced by hydrogen peroxide. Neurosci Lett. 2002, 326, 147-150.
104. Martin, M.; Macias, M.; Escames, G.; Leon, J.; Acuna-Castroviejo, D. Melatonin but not vitamins C and E maintains glutathione homeostasis in t-butyl hydroperoxide-induced mitochondrial oxidative stress. FASEB J. 2000, 14, 1677-1679.
105. Maharaj, D. S.; Walker, R. B.; Glass, B. D.; Daya, S. 6-Hydroxymelatonin protects against cyanide induced oxidative stress in rat brain homogenates. J. Chem. Neuroanat. 2003, 26, 103-107.
106. Seegar, H.; Mueck, A. O.; Lippert, T. H. Effect of melatonin and metabolites on copper-mediated oxidation of flow density lipoprotein. Br. J. Clin. Pharmacol. 1997, 44, 283-284.
107. Wolfler, A.; Abuja, P. M.; Schauenstein, K.; Liebmann, P. M. N-acetylserotonin is a better extra-and intracellular antioxidant than melatonin. FEBS Lett. 1999, 449, 206-210.
108. Manda, K.; Ueno, M.; Anzai, K. AFMK, a melatonin metabolite, attenuates X-ray-induced oxidative damage to DNA, proteins and lipids in mice. J. Pineal Res. 2007, 42, 386-393.
109. Fischer, T. W.; Scholz, G.; Knoll, B.; Hipler, U. C.; Elsner, P. Melatonin suppresses reactive oxygen species in UV-irradiated leukocytes more than vitamin C and trolox. Skin Pharmacol. Appl. Skin Physiol. 2002, 15, 367-373.
110. Fischer, T. W.; Scholz, G.; Knoll, B.; Hipler, U. C.; Elsner, P. Melatonin suppresses reactive oxygen species induced by UV irradiation in leukocytes. J. Pineal Res. 2004, 37, 107-112.
111. Sliwinski, T.; Rozej, W.; Morawiec-Bajda, A.; Morawiec, Z.; Reiter, R.; Blasiak, J. Protective action of melatonin against oxidative DNA damage: Chemical inactivation versus base-excision repair. Mutat. Res. 2007, 634, 220-227.
112. Semak, I.; Naumova, M.; Korik, E.; Terekhovich, V.; Wortsman, J.; Slominski, A. A novel metabolic pathway of melatonin: Oxidation by cytochrome C. Biochemistry 2005, 44, 9300-9307.
113. Letelier, M. E.; Jara-Sandoval, J.; Molina-Berrios, A.; Faundez, M.; Aracena-Parks, P.; Aguilera, F. Melatonin protects the cytochrome P450 system through a novel antioxidant mechanism. Chem. Biol. Interact. 2010, 185, 208-214.
114. Inarrea, P.; Casanova, A.; Alava, M. A.; Iturralde, M.; Cadenas, E. Melatonin and steroid hormones activate intermembrane Cu, Zn-superoxide dismutase by means of mitochondrial cytochrome P450. Free Radic. Biol. Med. 2011, 50, 1575-1581.
115. Semak, I.; Korik, E.; Antonova, M.; Wortsman, J.; Slominski, A. Metabolism of melatonin by cytochrome P450s in rat liver mitochondria and microsomes. J. Pineal Res. 2008, 45, 515-523.
116. Sainz, R. M.; Mayo, J. C.; Rodriguez, C.; Tan, D. X.; Lopez-Burillo, S.; Reiter, R. J. Melatonin and cell death: Differential actions on apoptosis in normal and cancer cells. Cell. Mol. Life Sci. 2003, 60, 1407-1426.
117. Costantini, P.; Belzacq, A. S.; Vieira, H. L.; Larochette, N.; de Pablo, M. A.; Zamzami, N.; Susin, S. A.; Brenner, C.; Kroemer, G. Oxidation of a critical thiol residue of the adenine nucleotide translocator enforces Bcl-2-independent permeability transition pore opening and apoptosis. Oncogene 2000, 19, 307-314.
118. Nieminen, A. L.; Byrne, A. M.; Herman, B.; Lemasters, J. J. Mitochondrial permeability transition in hepatocytes induced by t-BuOOH: NAD(P)H and reactive oxygen species. Am. J. Physiol. 1997, 272 4 Pt 1, C1286-C1294.
119. Byrne, A. M.; Lemasters, J. J.; Nieminen, A. L. Contribution of increased mitochondrial free Ca2+ to the mitochondrial permeability transition induced by tert-butylhydroperoxide in rat hepatocytes. Hepatology 1999, 29, 1523-1531.
120. Jou, M. J.; Peng, T. I.; Reiter, R. J.; Jou, S. B.; Wu, H. Y.; Wen, S. T. Visualization of the antioxidative effects of melatonin at the mitochondrial level during oxidative stress-induced apoptosis of rat brain astrocytes. J. Pineal Res. 2004, 37, 55-70.
121. Fischer, T. W.; Zmijewski, M. A.; Wortsman, J.; Slominski, A. Melatonin maintains mitochondrial membrane potential and attenuates activation of initiator (casp-9) and effector caspases (casp-3/casp-7) and PARP in UVR-exposed HaCaT keratinocytes. J. Pineal Res. 2008, 44, 397-407.
122. Andrabi, S. A.; Sayeed, I.; Siemen, D.; Wolf, G.; Horn, T. F. Direct inhibition of the mitochondrial permeability transition pore: A possible mechanism responsible for anti-apoptotic effects of melatonin. FASEB J. 2004, 18, 869-871.
123. Barr, D. P.; Mason, R. P. Mechanism of radical production from the reaction of cytochrome c with organic hydroperoxides. An ESR spin trapping investigation. J. Biol. Chem. 1995, 270, 12709-12716.
124. Bachurin, S. O.; Shevtsova, E. P.; Kireeva, E. G.; Oxenkrug, G. F.; Sablin, S. O. Mitochondria as a target for neurotoxins and neuroprotective agents. Ann. N. Y. Acad. Sci. 2003, 993, 334-344; discussion 345-349.
125. Martin, M.; Macias, M.; Leon, J.; Escames, G.; Khaldy, H.; Acuna-Castroviejo, D. Melatonin increases the activity of the oxidative phosphorylation enzymes and the production of ATP in rat brain and liver mitochondria. Int. J. Biochem. Cell. Biol. 2002, 34, 348-357.
126. Martin, M.; Macias, M.; Escames, G.; Reiter, R. J.; Agapito, M. T.; Ortiz, G. G.; Acuna-Castroviejo, D. Melatonin-induced increased activity of the respiratory chain complexes I and IV can prevent mitochondrial damage induced by ruthenium red in vivo. J. Pineal Res. 2000, 28, 242-248.
127. Acuna Castroviejo, D.; Lopez, L. C.; Escames, G.; Lopez, A.; Garcia, J. A.; Reiter, R. J. Melatonin-mitochondria interplay in health and disease. Curr. Top. Med. Chem. 2011, 11, 221-240.
128. Paradies, G.; Petrosillo, G.; Pistolese, M.; Ruggiero, F. M. The effect of reactive oxygen species generated from the mitochondrial electron transport chain on the cytochrome c oxidase activity and on the cardiolipin content in bovine heart submitochondrial particles. FEBS Lett. 2000, 466, 323-326.
129. Paradies, G.; Petrosillo, G.; Paradies, V.; Reiter, R. J.; Ruggiero, F. M. Melatonin, cardiolipin and mitochondrial bioenergetics in health and disease. J. Pineal Res. 2010, 48, 297-310.
130. Musatov, A.; Carroll, C. A.; Liu, Y. C.; Henderson, G. I.; Weintraub, S. T.; Robinson, N. C. Identification of bovine heart cytochrome c oxidase subunits modified by the lipid peroxidation product 4-hydroxy-2-nonenal. Biochemistry 2002, 41, 8212-8220.
131. Leon, J.; Acuna-Castroviejo, D.; Escames, G.; Tan, D. X.; Reiter, R. J. Melatonin mitigates mitochondrial malfunction. J. Pineal Res. 2005, 38, 1-9.
132. Tretter, L.; Sipos, I.; Adam-Vizi, V. Initiation of neuronal damage by complex I deficiency and oxidative stress in Parkinson's disease. Neurochem. Res. 2004, 29, 569-577.
133. Haas, R. H.; Nasirian, F.; Nakano, K.; Ward, D.; Pay, M.; Hill, R.; Shults, C. W. Low platelet mitochondrial complex I and complex II/III activity in early untreated Parkinson's disease. Ann. Neurol 1995, 37, 714-722.
134. Garcia, J. J.; Reiter, R. J.; Pie, J.; Ortiz, G. G.; Cabrera, J.; Sainz, R. M.; Acuna-Castroviejo, D. Role of pinoline and melatonin in stabilizing hepatic microsomal membranes against oxidative stress. J. Bioenerg. Biomembr. 1999, 31, 609-616.
135. Calvo, J. R.; Reiter, R. J.; Garcia, J. J.; Ortiz, G. G.; Tan, D. X.; Karbownik, M. Characterization of the protective effects of melatonin and related indoles against alpha-naphthylisothiocyanate-induced liver injury in rats. J. Cell. Biochem. 2001, 80, 461-470.
136. Garcia, J. J.; Reiter, R. J.; Karbownik, M.; Calvo, J. R.; Ortiz, G. G.; Tan, D. X.; Martinez-Ballarin, E.; Acuna-Castroviejo, D. N-acetylserotonin suppresses hepatic microsomal membrane rigidity associated with lipid peroxidation. Eur. J. Pharmacol. 2001, 428, 169-175.
137. Garcia, J. J.; Lopez-Pingarron, L.; Almeida-Souza, P.; Tres, A.; Escudero, P.; Garcia-Gil, F. A.; Tan, D. X.; Reiter, R. J.; Ramirez, J. M.; Bernal-Perez, M. Protective effects of melatonin in reducing oxidative stress and in preserving the fluidity of biological membranes: A review. J. Pineal Res. 2014, 56, 225-237.
138. Garcia, J. J.; Reiter, R. J.; Guerrero, J. M.; Escames, G.; Yu, B. P.; Oh, C. S.; Munoz-Hoyos, A. Melatonin prevents changes in microsomal membrane fluidity during induced lipid peroxidation. FEBS Lett. 1997, 408, 297-300.
139. Tan, D. X.; Manchester, L. C.; Liu, X.; Rosales-Corral, S. A.; Acuna-Castroviejo, D.; Reiter, R. J. Mitochondria and chloroplasts as the original sites of melatonin synthesis: A hypothesis related to melatonin's primary function and evolution in eukaryotes. J. Pineal Res. 2013, 54, 127-138.
140. Fischer, T. W.; Zbytek, B.; Sayre, R. M.; Apostolov, E. O.; Basnakian, A. G.; Sweatman, T. W.; Wortsman, J.; Elsner, P.; Slominski, A. Melatonin increases survival of HaCaT keratinocytes by suppressing UV-induced apoptosis. J. Pineal Res. 2006, 40, 18-26.
141. Janjetovic, Z.; Nahmias, Z. P.; Hanna, S.; Jarrett, S. G.; Kim, T. K.; Reiter, R. J.; Slominski, A. T. Melatonin and its metabolites ameliorate ultraviolet B-induced damage in human epidermal keratinocytes. J. Pineal Res. 2014, 57, 90-102.
142. Kleszczynski, K.; Tukaj, S.; Kruse, N.; Zillikens, D.; Fischer, T. W. Melatonin prevents ultraviolet radiation-induced alterations in plasma membrane potential and intracellular pH in human keratinocytes. J. Pineal Res. 2013, 54, 89-99.
143. Fischer, T. W.; Scholz, G.; Knoll, B.; Hipler, U. C.; Elsner, P. Melatonin reduces UV-induced reactive oxygen species in a dose-dependent manner in IL-3-stimulated leukocytes. J. Pineal Res. 2001, 31, 39-45.
144. Fischer, T. W.; Kleszczynski, K.; Hardkop, L. H.; Kruse, N.; Zillikens, D. Melatonin enhances antioxidative enzyme gene expression (CAT, GPx, SOD), prevents their UVR-induced depletion, and protects against the formation of DNA damage (8-hydroxy-2'-deoxyguanosine) in ex vivo human skin. J. Pineal Res. 2013, 54, 303-312.
145. Sarti, P.; Magnifico, M. C.; Altieri, F.; Mastronicola, D.; Arese, M. New Evidence for Cross Talk between Melatonin and Mitochondria Mediated by a Circadian-Compatible Interaction with Nitric Oxide. Int. J. Mol. Sci. 2013, 14, 11259-11276.
146. Ryoo, Y. W.; Suh, S. I.; Mun, K. C.; Kim, B. C.; Lee, K. S. The effects of the melatonin on ultraviolet-B irradiated cultured dermal fibroblasts. J. Dermatol. Sci. 2001, 27, 162-169.
147. Lee, K. S.; Lee, W. S.; Suh, S. I.; Kim, S. P.; Lee, S. R.; Ryoo, Y. W.; Kim, B. C. Melatonin reduces ultraviolet-B induced cell damages and polyamine levels in human skin fibroblasts in culture. Exp. Mol. Med. 2003, 35, 263-268.
148. Rezzani, R.; Rodella, L. F.; Favero, G.; Damiani, G.; Paganelli, C.; Reiter, R. J. Attenuation of ultraviolet A-induced alterations in NIH3T3 dermal fibroblasts by melatonin. Br. J. Dermatol. 2014, 170, 382-391.
149. Sander, C. S.; Chang, H.; Salzmann, S.; Muller, C. S.; Ekanayake-Mudiyanselage, S.; Elsner, P.; Thiele, J. J. Photoaging is associated with protein oxidation in human skin in vivo. J. Investig. Dermatol. 2002, 118, 618-625.
150. Fischer, T. W.; Elsner, P. The antioxidative potential of melatonin in the skin. Curr. Probl. Dermatol. 2001, 29, 165-174.
151. Tan, D. X.; Chen, L. D.; Poggeler, B.; Manchester, L. C.; Reiter, R. J. Melatonin: A potent, endogenous hydroxyl radical scavanger. Endocr. J. 1993, 1, 57-60.
152. Hardeland, R. Melatonin and the theories of aging: A critical appraisal of melatonin's role in antiaging mechanisms. J. Pineal Res. 2013, 55, 325-356.
153. Reiter, R. J.; Paredes, S. D.; Manchester, L. C.; Tan, D. X. Reducing oxidative/nitrosative stress: A newly-discovered genre for melatonin. Crit. Rev. Biochem Mol. Biol. 2009, 44, 175-200.
154. Lerner, A. B. The discovery of the melanotropins. A history of pituitary endocrinology. Ann. N. Y. Acad. Sci. 1993, 680, 1-12.
155. Lerner, A. B. Melatonin-Without the hype. Adv. Exp. Med. Biol. 1999, 460, 1-3.